Life After Chase: Ken Irvine Named to Alpha-1 Board

Foundation Fights Antitrypsin Deficiency

Chase Alumnus Kenneth Irvine of Greenwich, CT has been elected to the Board of Directors of the Alpha-1 Foundation, where he has served on the development committee for the past two years.

Mr. Irvine's wife, Bettina, who has Alpha-1(antitrypsin deficiency), received a double lung transplant on Thanksgiving weekend in 2004. Alpha-1 is one of the most common life- threatening hereditary disorders that results in severe lung or liver disease and often leads to the need for a transplant. The Alpha-1 Foundation has funded over $23 million in cutting edge research, such as gene therapy, stem cell studies and transgenic medicine, in its efforts to find a cure for Alpha-1. For more information, please contact the Alpha-1 Foundation.

Mr. Irvine is Head of Portfolio Management for Citadel Hill Advisors, the U.S. debt investment management subsidiary of The Bank of Nova Scotia. He worked for Chase in the United States and Japan from 1972 to 1989.